Fund HoldingsPatient Square Capital LP

Total Portfolio Value
$277.39M
Total Bought
$29.24M
Total Sold
$25.87M
Net Transaction
+$3.37M
Filing Period:
Securities
SharesValue ($K)
Q1 2025
Q2 2025
Change
Q1 2025
Q2 2025
Weight (%)
Change
ARGENX SE - ADR(ARGX)029,000+29,000015,9855.76%+15,985
ROIVANT SCIENCES LTD.(ROIV)12,480,00012,480,0000125,923140,65050.71%+14,726
INSMED INC(INSM)330,250358,800+28,55025,19536,11013.02%+10,915
EYEPOINT PHARMACEUTICALS, INC.(EYPT)1,481,9771,352,837-129,1408,03212,7304.59%+4,698
KYMERA THERAPEUTICS, INC.(KYMR)142,201140,000-2,2013,8926,1102.20%+2,218
GERON CORP(GERN)0716,000+716,00001,0100.36%+1,010
OCULAR THERAPEUTIX, INC.(OCUL)920,199817,699-102,5006,7457,5882.74%+843
CIDARA THERAPEUTICS INC015,000+15,00007310.26%+731
AGIOS PHARMACEUTICALS, INC.(AGIO)139,732139,73204,0944,6471.68%+553
MIRUM PHARMACEUTICALS, INC.(MIRM)116,362113,462-2,9005,2425,7742.08%+532
SCHOLAR ROCK HOLDING CORPORATION(SRRK)154,000154,00004,9515,4551.97%+504
PHARVARIS N. V.
COM
245,496244,283-1,2133,8544,2991.55%+445
VYNE THERAPEUTICS INC.257,033317,033+60,0004065230.19%+117
ENLIVEN THERAPEUTICS, INC.253,838245,838-8,0004,9964,9321.78%-64
CULLINAN THERAPEUTICS, INC.(CGEM)878,897868,897-10,0006,6536,5432.36%-110
DISC MEDICINE, INC.(IRON)83,00074,000-9,0004,1203,9191.41%-201
ALLOGENE THERAPEUTICS, INC.2,368,1862,635,000+266,8143,4582,9781.07%-480
NURIX THERAPEUTICS, INC.(NRIX)447,296412,296-35,0005,3144,6961.69%-618
SOLENO THERAPEUTICS, INC.18,6000-18,6001,3290-1,329
INTELLIA THERAPEUTICS, INC.(NTLA)232,7810-232,7811,6550-1,655
BLUEPRINT MEDICINES CORPORATION38,5000-38,5003,4080-3,408
LIQUIDIA CORPORATION(LQDA)1,522,4521,020,000-502,45222,45612,7094.58%-9,747
Page 1 of 1